Vitamin B2 (Riboflavin).
Boosts energy and supports cellular function. Turns your food into fuel. It's a key player in energy production at the cellular level. Also helps with antioxidant defense and keeping your skin and eyes healthy.
Reviewed March 2026
- Category
- Vitamin
- Also filed under
- Energy ProductionAntioxidant SupportMigraine ReliefSkin Health
What Vitamin B2 (Riboflavin) is, and what it does.
- Does it work
- Useful if your diet is light on dairy, eggs and green vegetables, or you eat entirely plant based. Eating those regularly usually covers the everyday requirement already.
- How much to take
- For general health, 10-25 mg daily is plenty. For migraines, studies use a hefty 400 mg daily. Don't start that high without talking to a doctor.
- Time to feel it
- Bright yellow urine turns up within hours, which is simply surplus clearing. Status markers such as glutathione reductase activity respond across a few weeks of daily use.
- The first dose
- Nothing, except startlingly yellow pee about an hour after you take it. This is not a stimulant.
- With regular use
- Could mean more stable energy levels and healthier skin. For migraine sufferers, it can mean fewer headaches after 2-3 months of consistent, high-dose use.
- How well tolerated
- Well tolerated. Your body gets rid of what it doesn't need. That yellow pee is just your body confirming it has enough.
- How it feels
- Subtle. You might just feel... normal, which is the point. The migraine relief is the most 'felt' benefit for those who respond.
- The overlooked benefit
- Riboflavin gates other B vitamins. The enzyme that activates vitamin B6 needs flavin mononucleotide, and the folate enzyme handling homocysteine is flavin dependent too.
10 to 25mg a day is where Vitamin B2 (Riboflavin) works.
Source: NIH ODS + Schoenen 1998 (migraine prevention at 400mg)
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Strong consensus on the essential role of riboflavin in metabolic processes and its safety at recommended doses. Research supports its use in managing migraines and certain genetic conditions.
- Reduces migraine frequency in adultsMeta-analysis of 11 clinical trials
- Lowers homocysteine levels (specifically in MTHFR 677TT genotype)Multiple RCTs (n>600 combined)
- Essential for ATP (cellular energy) productionEstablished Biochemical Fact
Questions people ask about Vitamin B2 (Riboflavin).
- Why does it make my pee bright yellow?
- That's the excess riboflavin leaving your body. It's natural, completely harmless, and a sign you're well-supplied.
- Can I get enough from food?
- For basic needs, yes. Dairy, almonds, and lean meats are good sources. For the high doses used for migraines, you'd need a supplement.
- Is it safe to take every day?
- Yes. It's a water-soluble vitamin, so your body just excretes what it doesn't use. No need to cycle it.
- Will it give me an energy boost like caffeine?
- No. It helps your body produce energy from food more efficiently. It's a background process, not a stimulant kick.
- When is the best time to take it?
- Anytime. With or without food. Just be consistent.
- Will it actually stop my migraines?
- It might. Studies show that 400mg daily reduces migraine frequency by about 50% in about half the people who try it. It takes 2-3 months to see results.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Riboflavin's coenzyme form FMN powers the enzyme that converts vitamin B6 into its active form, pyridoxal 5'-phosphate. Without enough riboflavin the body cannot fully activate B6, so steady riboflavin keeps B6 ready for its part in amino acid and neurotransmitter metabolism.
As its coenzyme FAD, riboflavin is the cofactor for MTHFR, the enzyme that produces the active circulating form of folate, 5-methyltetrahydrofolate. Steady riboflavin keeps that conversion running, so folate can carry out its part in one-carbon and methylation metabolism.
Flavoenzymes that depend on riboflavin support the normal absorption of iron and the release of stored iron from ferritin. With adequate riboflavin, the body makes fuller use of the iron it takes in from food and supplements.
Riboflavin, as FAD, is required by the enzyme that carries tryptophan along the route the body uses to make its own niacin and NAD. Adequate riboflavin supports that internal niacin production alongside what the diet provides.
The FAD built from riboflavin drives methionine synthase reductase, which restores the oxidised cobalamin cofactor. Riboflavin status therefore limits how much of the cobalamin present stays usable.
Glutathione reductase is a flavoprotein that uses FAD to return oxidised glutathione to its reduced form. Riboflavin supply sets how fast the glutathione pool is recycled.
Riboflavin has to be phosphorylated to FMN and then adenylylated to FAD, and both steps are magnesium-dependent ATP reactions. Without magnesium the vitamin stays in its inactive form.
Riboflavin kinase, the enzyme that makes FMN, is a zinc-dependent kinase. Zinc availability is part of converting dietary riboflavin into its coenzyme.
Complex I and complex II are flavoproteins that depend on FMN and FAD, and both hand their electrons to the coenzyme Q pool. Riboflavin loads the chain and CoQ10 carries the electrons onward.
Carnitine carries long-chain acyl groups into the mitochondrion and the acyl-CoA dehydrogenases that then shorten them are FAD enzymes. Riboflavin status limits the step immediately after transport.
Dihydrolipoamide dehydrogenase, the shared E3 subunit of the dehydrogenase complexes, is an FAD flavoprotein that re-oxidises the lipoamide arm. Riboflavin keeps the lipoate cycle turning.
Glutathione peroxidase is a selenoenzyme that consumes reduced glutathione, and the enzyme that regenerates that glutathione, glutathione reductase, is FAD dependent and so depends on riboflavin. Without flavin supply the selenium enzyme runs out of reduced substrate. This is one of the tightest cofactor links in antioxidant biochemistry.
Xanthine oxidase and aldehyde oxidase each hold a molybdenum centre and an FAD in the same protein, so both trace nutrients are structural requirements of a single enzyme. Neither cofactor substitutes for the other. That makes the pairing a requirement statement rather than an optimisation claim.
Converting pyridoxine or pyridoxamine phosphate to the active pyridoxal 5-phosphate is done by an oxidase that carries FMN, a riboflavin derived cofactor. Low riboflavin status therefore limits activation of vitamin B6 regardless of how much B6 is supplied. Supplying B6 already in the 5-phosphate form is how a formula sidesteps that step.
The body can make some of its niacin from tryptophan, and one of the committed steps in that route is carried out by an FAD dependent monooxygenase. When riboflavin is short, that conversion slows and more tryptophan leaves the pathway as other metabolites. It is a good illustration of how one B vitamin gates the use of another.
Oxidising choline to betaine aldehyde, the first step toward using choline as a methyl donor, is carried out by an FAD dependent dehydrogenase. Riboflavin therefore sits upstream of choline's methyl donor role. Choline's separate role in phospholipid synthesis does not depend on flavins.
Every round of mitochondrial fatty acid beta oxidation begins with an acyl-CoA dehydrogenase that uses FAD and passes electrons on through electron transfer flavoprotein, which is also flavin dependent. Long chain fatty acids from fish oil are handled by that machinery. Riboflavin supply is therefore part of what determines how well an ingested fat is oxidised rather than stored.
Alpha tocopherol is regenerated from its radical form with help from ascorbate and glutathione, and glutathione is returned to its reduced state by the FAD dependent glutathione reductase. Riboflavin thus supports the loop that keeps vitamin E working in the membrane. The measured endpoints here are redox markers.
N-acetylcysteine supplies cysteine for glutathione synthesis while riboflavin, as FAD, powers the reductase that keeps that glutathione in its reduced form. One provides the material and the other maintains its state. Together they act on glutathione status, which is a marker rather than an outcome.
Homocysteine can be remethylated either by the folate route, whose MTHFR step needs FAD and so depends on riboflavin, or by the betaine dependent route, which does not. Supplying both means neither route is the sole path. The endpoint here is a plasma homocysteine measurement, a marker.
MTHFR, the enzyme that makes the methyl folate used to regenerate methionine, is an FAD dependent flavoenzyme, which puts riboflavin upstream of the methionine that becomes S-adenosylmethionine. Supplemental SAM-e enters below that step. The relationship is pathway position, not an additive effect.
Thiamine and riboflavin both feed mitochondrial energy production, thiamine as the pyrophosphate cofactor of dehydrogenase complexes and riboflavin as FAD within the same complexes and in the respiratory chain. A dietary intake analysis reported associations between intake of these vitamins and blood pressure measures, and an association is not a cause. The mechanistic overlap is the sounder half of this pairing.
Pantothenate becomes coenzyme A, which carries the acyl groups that FAD dependent dehydrogenases then oxidise, so the two vitamins handle consecutive parts of fat and carbohydrate oxidation. Neither compensates for a shortage of the other. This is why B complex products carry the set rather than single members.
Several lactic acid bacteria and other commensals synthesise riboflavin, and some strains are selected specifically for that capacity, while riboflavin also acts as an extracellular electron shuttle for certain gut species. So the relationship runs in both directions and the size of the contribution to a person's intake is not established. Colonic synthesis is also absorbed less efficiently than dietary riboflavin from the small intestine.
Riboflavin absorbs visible light and generates reactive oxygen species when it does, which degrades ascorbate, folate and tryptophan in the same solution; this is the same chemistry behind light induced losses in milk. In a liquid product that puts riboflavin and vitamin C in direct conflict unless the container blocks light. In a dry capsule the effect is negligible.
Talk to a doctor before taking Vitamin B2 (Riboflavin) if any of these apply to you: Pregnancy and breastfeeding (consult a doctor), Individuals with kidney problems (high doses). These are flags to check first, not effects Vitamin B2 (Riboflavin) is known to cause.
Not medical advice. Show the label to your pharmacist.What Vitamin B2 (Riboflavin) actually does.
Riboflavin, or vitamin B2, is the starting material for two working forms: one enzyme adds a phosphate to make flavin mononucleotide, and another adds more to make flavin adenine dinucleotide. Your enzymes use those two, not riboflavin itself.
The working form FAD is needed by succinate dehydrogenase, which is step two of your mitochondrial energy chain, and by the enzymes that burn fat for fuel. That's the direct biochemical reason riboflavin matters for making ATP.
The enzyme MTHFR needs FAD to work, so your riboflavin status affects how folate helps recycle homocysteine. The effect is largest in people whose version of that enzyme holds onto its flavin less tightly.
Glutathione reductase needs FAD, which is why labs measure how much its activity in red blood cells jumps when flavin is added, as a functional test of riboflavin status. That's a status marker, not a health outcome.
Where Vitamin B2 (Riboflavin) comes from.
Most riboflavin is grown. A microbe is fed sugar or oil and makes so much of the vitamin that it crystallises out, and those crystals are washed and purified to a set standard. There is also an older route that builds the molecule chemically, and the end result is the same compound either way. To make the more soluble version used in liquids, a phosphate group is added to the purified vitamin. Everything is packed away from light, because riboflavin breaks down when light hits it.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
Fermentation routes feed a simple carbon source, commonly glucose, molasses or a vegetable oil, to the production organism
A production strain, historically the fungus Ashbya gossypii and now often an engineered Bacillus subtilis, overproduces riboflavin and secretes or accumulates it; a regulatory dossier for a fermentation produced riboflavin additive documents this route
The older synthetic route builds the ring system from ribose and a substituted aniline with a barbituric acid condensation; it is still used and gives the identical molecule
For fermentation material the broth is heat treated and the biomass separated, since much of the riboflavin crystallises out of solution as its concentration rises
Crude riboflavin is redissolved, decolourised and recrystallised to specification, with residual protein and fermentation solids removed
Purity is set against a pharmacopoeial monograph and the crystals are milled to a defined particle size, or phosphorylated and salted to make riboflavin 5-phosphate sodium
Milled powder is used directly in tablets and capsules, granulated for flow, or dissolved as the phosphate salt for liquid products, all packaged to exclude light
Finished labels almost never say whether the riboflavin was fermented or synthesised, or which organism was used, which is the detail that matters for anyone screening for a fermentation derived ingredient.
Getting Vitamin B2 (Riboflavin) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- In adults with the MTHFR 677TT genotype, riboflavin at 1.6 mg a day lowered systolic blood pressure by about 5.6 mmHg over 16 weeks.Randomised trial. Wilson et al., 2013 (Hypertension). PMID 23608654 ↗
- Pooling randomised trials, riboflavin lowered the monthly number of headache attacks by about 1.3 compared with control.Meta-analysis. Talandashti et al., 2024 (Neurological Sciences). PMID 39404918 ↗
- One month of daily supplementation raised blood riboflavin by 0.77 standard deviation units and cut the proportion of women with low riboflavin status.Randomised trial. Godfrey et al., 2023 (PLoS Medicine). PMID 38051700 ↗
- In 43 adults, 100 mg vitamin B1 taken together with 100 mg vitamin B2 daily for four weeks lowered perceived stress scores from 21.5 to 15.5 and improved sleep quality scores, with no detectable change in anxiety scores; the two vitamins were given as one combination, so B2 alone was not isolated.Randomised trial. Tao et al., 2025 (Nutrients). PMID 40507089 ↗
- In 72 adults eating a plant-only diet, four months of a multinutrient supplement raised blood flavin adenine dinucleotide, a marker of riboflavin status rather than a health outcome, more than placebo, while several other vitamin markers showed no between-group difference.Randomised trial. Zerback et al., 2025 (European Journal of Nutrition). PMID 41417236 ↗
- Reviewed riboflavin deficiency and supplementation against energy metabolism endpoints and concluded the evidence base is dominated by preclinical work, which supports the flavin cofactor role in energy production rather than an effect size in people.Systematic review. da Silva-Araujo ER et al., 2025 (Nutrition reviews). PMID 38719205 ↗
- Systematically reviewed how effective riboflavin is in people with inherited differences in metabolism, where the rationale is that supraphysiological flavin can stabilise a poorly folded flavoenzyme; findings apply to those specific inherited settings, not to general use.Systematic review. Jaeger B et al., 2026 (Journal of inherited metabolic disease). PMID 42046426 ↗
- Reported associations between dietary thiamin, riboflavin and niacin intake and blood pressure measures including pulse pressure; these are observational associations, not evidence that changing intake changes blood pressure.Cohort study. Ma S et al., 2026 (Medicine). PMID 42299541 ↗
- A structured narrative review of observational evidence on riboflavin and other B vitamin intake and long term risk outcomes, reporting associations that the authors describe as inconsistent across studies; association, not causation.Narrative review. Bertuccioli A et al., 2026 (Pathology oncology research). PMID 42403423 ↗
- A regulatory panel assessment of a riboflavin 80 percent additive produced by microbial fermentation, which documents the fermentation production route and the identity specifications used for commercial riboflavin.Narrative review. EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) et al., 2026 (EFSA journal). PMID 42206214 ↗
- Riboflavin altered complement activation, immune cell viability and neutrophil microbicidal function in non-human experiments; mechanistic and preclinical, with no human immune outcome measured.Animal study. Torres-Aguilar H et al., 2026 (Immunological investigations). PMID 42377069 ↗
- Reviewed nutraceutical products containing vitamin B2 in children and adolescents; riboflavin is one component of the reviewed products rather than the isolated variable, so nothing here isolates riboflavin or describes what it does on its own.Systematic review. Martello E et al., 2025 (Acta paediatrica). PMID 40411246 ↗
- Reviewed B complex supplementation outcomes in gum and supporting tissue health across age groups, with riboflavin named as one vitamin within the complex; the intervention is the complex, so nothing here isolates riboflavin.Systematic review. Buzatu R et al., 2025 (Nutrients). PMID 40218924 ↗
- Reported that exclusive breastfeeding did not deliver adequate B vitamin status, riboflavin among them, in very low birth weight preterm infants; a status marker in a specific vulnerable population, observed rather than tested.Cohort study. Bjorke-Monsen AL et al., 2026 (Nutrients). PMID 41683246 ↗
These are the studies our verdict leans on, chosen from the 640 we read for Vitamin B2 (Riboflavin). The full linked list is below.
Problems people have reported.
Read this carefully. These are 229 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Vitamin B2 (Riboflavin) is, not how risky it is. A report is not proof Vitamin B2 (Riboflavin) caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.





